Thursday, August 23, 2012

Oncogene - Table of Contents alert Volume 31 Issue 34

TABLE OF CONTENTS

Volume 31, Issue 34 (August 2012)

In this issue
Review
Original Articles

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer
T Hulf, S J Clark and colleagues ¦ doi:10.1038/onc.2012.300

In this article recently published in Oncogene Researchers at Sydney's Garvan Institute have revealed the role of one non-coding microRNA (miRNA) which appears to play a significant role in prostate cancer and is closely linked to the prognosis of cancer patients.
 

Review

Top

Targeting the epigenome for treatment of cancer

E-J Geutjes, P K Bajpe and R Bernards

Oncogene 2012 31: 3827-3844; advance online publication, December 5, 2011; 10.1038/onc.2011.552

Abstract | Full Text

Original Articles

Top

Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells

P Khanal, H J Yun, S C Lim, S G Ahn, H E Yoon, K W Kang, R Hong and H S Choi

Oncogene 2012 31: 3845-3856; advance online publication, December 12, 2011; 10.1038/onc.2011.548

Abstract | Full Text

Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis

D Palmieri, D D'Angelo, T Valentino, I De Martino, A Ferraro, A Wierinckx, M Fedele, J Trouillas and A Fusco

Oncogene 2012 31: 3857-3865; advance online publication, December 5, 2011; 10.1038/onc.2011.557

Abstract | Full Text

MiR-135a functions as a selective killer of malignant glioma

S Wu, Y Lin, D Xu, J Chen, M Shu, Y Zhou, W Zhu, X Su, Y Zhou, P Qiu and G Yan

Oncogene 2012 31: 3866-3874; advance online publication, December 5, 2011; 10.1038/onc.2011.551

Abstract | Full Text

Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation

D Balli, X Ren, F-S Chou, E Cross, Y Zhang, V V Kalinichenko and T V Kalin

Oncogene 2012 31: 3875-3888; advance online publication, December 5, 2011; 10.1038/onc.2011.549

Abstract | Full Text

Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis

M R Cronan, K Nakamura, N L Johnson, D A Granger, B D Cuevas, J-G Wang, N Mackman, J E Scott, H G Dohlman and G L Johnson

Oncogene 2012 31: 3889-3900; advance online publication, December 5, 2011; 10.1038/onc.2011.544

Abstract | Full Text

The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas

L Li, J Ying, H Li, Y Zhang, X Shu, Y Fan, J Tan, Y Cao, S W Tsao, G Srivastava, A T C Chan and Q Tao

Oncogene 2012 31: 3901-3912; advance online publication, December 5, 2011; 10.1038/onc.2011.541

Abstract | Full Text

Advertisement
Nature Genetics and the Wellcome Trust present:
The Genomics of Common Diseases 2012
September 19-22, 2012 - Potomac, MD, USA

Keynote Speakers: Francis Collins (National Institutes of Health, USA), Thomas Hudson (Ontario Institute for Cancer Research, Canada), Neil Risch (University of California, San Francisco, USA), Sarah Tishkoff (University of Pennsylvania School of Medicine, USA)

Register today!
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: